Shuttle Pharmaceuticals Holdings, Inc.
Pharmaceutical company · Gaithersburg, Maryland, United States · Nasdaq: SHPH
Shuttle Pharmaceuticals Holdings, Inc. is a pharmaceutical company headquartered in Gaithersburg, Maryland, United States. Its earliest recorded incorporation is in 2018. Its shares trade on Nasdaq under the ticker SHPH. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2025.
Shuttle Pharmaceuticals Holdings at a glance
What does Shuttle Pharmaceuticals Holdings do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $2.5 million sold (2025).
Frequently asked questions about Shuttle Pharmaceuticals Holdings
Where is Shuttle Pharmaceuticals Holdings headquartered?
Shuttle Pharmaceuticals Holdings, Inc. is headquartered in Gaithersburg, Maryland, United States.
What does Shuttle Pharmaceuticals Holdings do?
Shuttle Pharmaceuticals Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Shuttle Pharmaceuticals Holdings a public company?
Yes. Shuttle Pharmaceuticals Holdings, Inc. trades on Nasdaq under the ticker SHPH.
When was Shuttle Pharmaceuticals Holdings founded?
The earliest incorporation on record for Shuttle Pharmaceuticals Holdings, Inc. is in 2018, according to public company registers.
Similar companies
- Emergent BioSolutions Inc.Gaithersburg, Maryland, United States
- Genvec IncGaithersburg, Maryland, United States
- Altimmune, Inc.Gaithersburg, Maryland, United States
- NexImmune, Inc.Gaithersburg, Maryland, United States
- Viela Bio, Inc.Gaithersburg, Maryland, United States
- Adaptive Phage Therapeutics, Inc.Gaithersburg, Maryland, United States
- Remedy Plan, Inc.Gaithersburg, Maryland, United States
- BullFrog AI Holdings, Inc.Gaithersburg, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences